Kalali Amir H — SEC insider filings
SEC reporting owner CIK 1403646. 8 insider filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-06-24 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 4,666 shares, $69,990 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 4,666 shares @ $15.00 ($69,990) in ATAI Life Sciences N.V., filed 2021-06-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ATAI Life Sciences N.V. (ATAI) | Director | 6 | 1 leg · 4,666 sh · $69,990 | — | 5 |
| AtaiBeckley Inc. (ATAI) | Director | 2 | — | — | 7 |
Insider filings — Kalali Amir H
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | AtaiBeckley Inc. (ATAI) | Disposition to issuer (D): 4,666 · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-06-08 | 4 | AtaiBeckley Inc. (ATAI) | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | ATAI Life Sciences N.V. (ATAI) | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | ATAI Life Sciences N.V. (ATAI) | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | ATAI Life Sciences N.V. (ATAI) | Grant/award (A): 64,000 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | ATAI Life Sciences N.V. (ATAI) | Grant/award (A): 64,000 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | ATAI Life Sciences N.V. (ATAI) | Grant/award (A): 128,000 (derivative) @ $0 | EDGAR |
| 2021-06-24 | 4 | ATAI Life Sciences N.V. (ATAI) | Purchase (P): 4,666 @ $15 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1403646 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs